IGA urges the public not to cut back on eye tests

Article

The International Glaucoma Association (IGA) is urging people not to cut back on eye tests due to the recession.

The International Glaucoma Association (IGA) is urging people not to cut back on eye tests due to the recession. It is estimated that the total cost of sight loss in the UK alone is £4.8 billion a year. June 8th–14th is National Glaucoma Awareness Week in the UK and a campaign is urging everyone over the age of 40 to have a sight test at least once every two years.

David Wright, chief executive officer of the IGA commented: "A comprehensive eye test for glaucoma including all three glaucoma tests is painless and quick and amazingly good value for money when compared with the consequences of losing your vision.

"Let us not come out of this recession, whenever that may be, with a recession legacy of blind and partially sighted people who had 'nothing wrong with their sight' when they decided not to have their eyes tested."

Doctors can obtain free posters and leaflets by calling +44 1233 648170 or email info@iga.org.uk

Related Videos
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
 Allen Ho, MD, presented a paper on the 12 month results of a mutation agnostic optogenetic programme for patients with severe vision loss from retinitis pigmentosa
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
ARVO 2024: President-elect SriniVas Sadda, MD, speaks with David Hutton of Ophthalmology Times
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Paul Kayne, PhD, on assessing melanocortin receptors in the ocular space
Osamah Saeedi, MD, MS, at ARVO 2024
© 2024 MJH Life Sciences

All rights reserved.